XERIS BIOPHARMA HOLDINGS INC

Ticker: XERS CUSIP: 98422E103 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 80,420 Value ($000) $655 Avg Close $6.64 Range $4.52 - $8.35

Q2 2025

Shares 80,420 Value ($000) $376 Avg Close $4.58 Range $3.81 - $5.50

Q1 2025

Shares 80,420 Value ($000) $442 Avg Close $4.04 Range $3.14 - $6.07

Q4 2024

Shares 80,420 Value ($000) $273 Avg Close $3.22 Range $2.69 - $3.87

Q3 2024

Shares 80,420 Value ($000) $229 Avg Close $2.57 Range $2.03 - $3.04

Q2 2024

Shares 80,420 Value ($000) $181 Avg Close $2.02 Range $1.69 - $2.51

Q1 2024

Shares 80,420 Value ($000) $178 Avg Close $2.59 Range $2.00 - $3.26

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	80,420	$655	$6.64	$4.52 - $8.35
Q2 2025	80,420	$376	$4.58	$3.81 - $5.50
Q1 2025	80,420	$442	$4.04	$3.14 - $6.07
Q4 2024	80,420	$273	$3.22	$2.69 - $3.87
Q3 2024	80,420	$229	$2.57	$2.03 - $3.04
Q2 2024	80,420	$181	$2.02	$1.69 - $2.51
Q1 2024	80,420	$178	$2.59	$2.00 - $3.26